Intercept Pharmaceuticals (ICPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 59,382 | 77,720 | 48,871 | 70,013 | 120,244 |
| Marketable Securities | 429,711 | 460,618 | 277,221 | 344,904 | 372,506 |
| Receivables | 22,080 | 19,509 | 16,944 | 16,501 | 14,487 |
| TOTAL | $528,918 | $577,740 | $363,845 | $448,307 | $521,515 |
| Non-Current Assets | |||||
| PPE Net | 11,322 | 12,453 | 14,074 | 16,184 | 18,141 |
| Other Non-Current Assets | 16,713 | 14,721 | 15,899 | 19,856 | 20,770 |
| TOTAL | $28,035 | $27,174 | $29,973 | $36,040 | $38,911 |
| Total Assets | $556,953 | $604,914 | $393,818 | $484,347 | $560,426 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 83,058 | 79,606 | 74,087 | 94,777 | 82,070 |
| TOTAL | $88,417 | $88,703 | $79,446 | $104,034 | $87,589 |
| Non-Current Liabilities | |||||
| Long Term Debt | 367,233 | 363,300 | 359,449 | 355,677 | 351,984 |
| Deferred Revenues | 1,622 | 1,622 | 1,622 | 1,782 | 1,782 |
| Other Non-Current Liabilities | 4,278 | 4,713 | 5,171 | 5,578 | 6,068 |
| TOTAL | $372,727 | $369,635 | $366,647 | $363,927 | $361,170 |
| Total Liabilities | $461,144 | $458,338 | $446,093 | $467,961 | $448,759 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 29,654 | 29,565 | 25,332 | 25,173 | 25,102 |
| Common Shares | 30 | 29 | 25 | 25 | 25 |
| Retained earnings | -1,690,780 | -1,626,326 | -1,551,133 | -1,469,543 | -1,358,271 |
| Other shareholders' equity | -1,646 | -2,082 | -643 | -786 | -632 |
| TOTAL | $95,809 | $146,576 | $-52,275 | $16,386 | $111,667 |
| Total Liabilities And Equity | $556,953 | $604,914 | $393,818 | $484,347 | $560,426 |